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Abstract: The effects of implantation of a dialysis probe into 
the striatum of awake rats on indices of dopamine (DA) and 
serotonin neurotransmission were assessed, first over 24 h 
following initial insertion of a probe, and then again following 
reinsertion of a probe at the same site 1 week later. It was 
found that the basal concentration of DA in dialysate sta- 
bilized within 20-40 min after probe implantation, although 
DA showed a modest decline 24 h later. There was, however, 
no significant difference in basal DA between two test sessions 
separated by 1 week. On the other hand, the basal concen- 
trations of the DA metabolites, 3,4-dihydroxyphenylacetic 
acid and homovanillic acid, progressively increased for 2-3 
h after probe implantation and decreased markedly by 24 h 
later. Furthermore, in contrast to DA, the DA metabolites 
decreased even further after the second probe insertion. Am- 
phetamine-stimulated DA release was also greatly attenuated 
following the second probe insertion, relative to the first probe 
insertion. Two probe insertions had only modest effects on 
the concentration of 5-hydroxyindoleacetic acid in dialysate, 
relative to the DA metabolites. It is suggested the effects of 
two probe insertions on DA metabolism and amphetamine- 
stimulated DA release described here are indicative of probe- 
induced damage to the nigrostriatal DA system. If this is the 
case, multiple probe insertions may not provide a feasible 
strategy for within-subjects design dialysis experiments over 
extended periods of time, at least in the DA system of small 
animals. It is suggested further that a stable basal concentra- 
tion of DA in dialysate may be an especially poor indicator 
of the integrity of the dopaminergic input to the striatum. 
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In vivo microdialysis is becoming an increasingly 
popular sampling technique for studying the neuro- 
chemistry of the extracellular environment in awake 
animals (Ungerstedt, 1984). The technique is relatively 
new, however, and its strengths and limitations are still 
a topic of investigation (Westerink et al., 1987). For 
example, it would be advantageous if microdialysis 
could be used for repeated sampling over long periods 
of time (days to weeks), because this would permit the 
use of within-subjects design experiments. There have 
been a few studies on the use of continuous intracerebral 
dialysis sampling for 7- 10 days. These have not been 
very promising because of a progressive decline in the 
amount of neurotransmitter recovered in dialysate 
(Imperato and Di Chiara, 1984, 1985; Korf and Ve- 
nema, 1985; Westerink and Tuinte, 1986; Reiriz et al., 
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1989), which has been attributed to impeded diffusion 
caused by the formation of a glial barrier around the 
dialysis membrane (Westerink and Tuinte, 1986; Ben- 
veniste and Dierner, 1987; cf., Robinson and Camp, 
199 1 b). 
There are, however, alternatives to continuous sam- 
pling. For example, it may be less disruptive to use 
multiple insertions of a dialysis probe into the brain, 
at different points in time, via the same guide cannula. 
This approach has been used in experiments involving 
push-pull perfusion (Myers, 1977). We know of only 
two reports involving multiple probe insertions for 
within-subjects design dialysis experiments in the me- 
sostriatal dopamine (DA) system (Kalivas and Duffy, 
1990; Pettit and Justice, 199 1 ), but neither of these was 
intended specifically to characterize the procedure. 
Abbreviations used: ANOVA, analysis of variance; DA, dopamine; 
DOPAC, 3,4dihydroxyphenylacetic acid; 5-HIAA, 5-hydroxyindo- 
leacetic acid; HVA, homovanillic acid; 6-OHDA, 6-hydroxydopa- 
mine; TTX, tetrodotoxin. 
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Thus, the purpose of experiments reported here was to  
characterize the effects of one or two insertions of a 
small diameter, concentric-style dialysis probe into the 
same site in the neostriatum on indices of DA and 
serotonin function. 
MATERIALS AND METHODS 
Subjects, surgical procedures, and probe 
implantation 
Holtzman rats weighing 250-350 g were anesthetized with 
sodium pentobarbital, supplemented with methoxyflurane; 
unilateral (experiment 1) or bilateral (experiments 2 and 3) 
21-gauge stainless steel guide cannulae (8 mm long) were 
placed on the dural surface above the corpus of the striatum, 
and fixed to the skull with dental cement, using standard 
stereotaxic techniques. A stylet (26-gauge stainless steel wire) 
protruded 1 mm beyond the tip of the cannula to maintain 
patency. Animals were allowed to recover for at least 1 week 
before dialysis experiments began. During this time and be- 
tween dialysis test sessions, animals were housed singly in 
hanging wire cages in a light-controlled room (lights on at 
0600, off at 2000), with free access to food and water. 
Before a dialysis probe (described below) was lowered into 
the striatum via the guide cannula, it was connected to a 
liquid swivel (Instech Labs) and the perfusion solution was 
pumped through the probe at 1.5 pl/min. In the first exper- 
iment, the perfusion solution, which was always filter-ster- 
ilized, consisted of 128.3 mMNaCl,2.68 mMKC1, 1.35 mM 
CaC12, and 2.0 mM MgC12, pH 7.3. In the second and third 
experiments, the perfusion solution contained 145 mMNaCI, 
2.7 mM KCI, 1.2 mM CaC12, 1 .O mM MgCI2, and 0.2 mM 
ascorbic acid, pH 7.3 (Moghaddam and Bunney, 1989). Im- 
mediately prior to probe implantation, each rat was lightly 
anesthetized with methoxyflurane and a dialysis probe man- 
ually lowered into the striatum via the guide cannula and 
fixed in place. An elastic harness was fitted about the torso 
of each animal, and this was connected to the swivel via a 
flexible tether constructed from model airplane control cable. 
The animals were then placed into test chambers, with food 
and water freely available. Dialysate was collected into 400- 
p1 polyethylene tubes mounted on the tether approximately 
30-40 cm above the animal. 
Experiment 1: Effects of continuous dialysis over 24 
h after probe insertion on the basal concentrations of 
DA, 3,4-dihydroxyphenylacetic acid (DOPAC), 
homovanillic acid (HVA), and 5-hydroxyindoleacetic 
acid (5-HIAA) in dialysate 
Both male (n = 5) and female (n = 8) rats were used in 
this experiment. Beginning no longer than 5 min after a probe 
was lowered into the striatum, nine consecutive 20-min sam- 
ples of dialysate were collected, with the perfusion solution 
pumped at a rate of 1.5 pl/min. Following collection of the 
last sample, the pump was turned down to 0.3 pl/min, and 
the animals were then left in the test chambers overnight 
with their probe in place. 
At approximately 0900, the day after probe implantation, 
the pump was again set at 1.5 pl/min, and after 15-30 min, 
five 20-min baseline samples were collected. After the last 
sample was obtained, the probe was removed, the stylet placed 
back into the guide cannula, and animals returned to their 
home cage; 3-5 days later, animals were given an overdose 
of chloral hydrate, perfused through the heart with 0.9% sa- 
line, followed by 10% formalin in saline, and the brains were 
removed for histological analysis. The brains were cut using 
a frozen technique, and 40-pm horizontal sections were 
stained with cresyl violet. 
In addition, to determine if basal DA release was tetro- 
dotoxin (TTX)-sensitive, the normal perfusion solution was 
replaced with one containing 0.5 pLM TTX in a subset of 
animals (n = 7), after collecting normal basal samples on 
each day of dialysis. 
Experiment 2: Effects of two probe insertions 
separated by 1 week on the basal concentrations of 
DA, DOPAC, HVA, and 5-HIAA in dialysate 
First probe insertion. Male rats were prepared with bilateral 
guide cannulae as described above. At least 5 days following 
surgery, a dialysis probe was lowered into one (n = 2) or both 
(n = 4) striata via the guide cannulae and fixed in place. 
Beginning no longer than 5 min after the probe was lowered 
into the striaturn, nine consecutive 20-min samples of dialy- 
sate were collected, with the perfusion solution pumped at 
1.5 pl/min. The pump was then turned down to 0.3 &min 
and the animals left in the test chambers overnight with the 
probes in place. At approximately 0900 the next day, the 
pump was again set at 1.5 pl/min, and after 15-30 min, at 
least three 20-min baseline samples were collected. After the 
last sample was obtained, the probes were removed, the stylets 
placed back into the guide cannulae, and animals returned 
to their home cage. 
Second probe insertion. One week later, a second dialysis 
experiment was performed on these same animals. In this 
experiment, dialysis probes were again lowered into one or 
both striata via the bilaterally positioned guide cannulae, and 
the experimental protocol was exactly as described following 
the first probe insertion. At the end of this experiment, all 
animals received an overdose of sodium pentobarbital, and 
after the probes were removed, the animals were perfused 
and the brains obtained for histological analysis, as in ex- 
periment 1. 
Experiment 3: Effects of two probe insertions 
separated by 1 week on basal and amphetamine- 
induced changes in DA, DOPAC, HVA, and 5-HIAA 
First probe insertion. Male rats were prepared with bilateral 
guide cannulae as described above. On the day before the 
first dialysis test session, a dialysis probe was lowered into 
the striatum in one hemisphere via one of the guide cannulae 
(right and left sides balanced within each group) and fixed 
in place. Animals were then placed into the test chambers 
and left there overnight, undisturbed, with the perfusion fluid 
pumped at 0.3 pl/min. 
The first dialysis test session began 16-20 h after a probe 
was lowered. The pump speed was increased to 1.5 pl/min, 
and after 15-30 min, baseline samples of dialysate were col- 
lected. After at least three 20-min baseline samples were col- 
lected, animals received intraperitoneally either 2.0 mg/kg 
d-amphetamine sulfate (weight of the salt; n = 14) or 0.9% 
saline (1 ml/kg; n = 6), and then sample collection continued 
for 200 min. After this, the probe was removed, a stylet placed 
into the guide cannula, and the animals returned to their 
home cage. Half the animals given amphetamine during this 
test session received three additional injections of amphet- 
amine (5.0 mg/kg) in their home cage, on each of the next 3 
days (group AMPH-4), and all other animals received saline. 
Second probe insertion. One week after the first dialysis 
test session, a second dialysis experiment was performed on 
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these same animals. In this test session, dialysis probes were 
lowered into the striatum in both hemispheres via the bilat- 
erally positioned guide cannulae. The experimental protocol 
was exactly as described following the first probe insertion, 
except all animals received an injection of 2.0 mg/kg am- 
phetamine following collection of baseline samples. 
Thus, some animals received amphetamine for the first 
time during the second dialysis test session, i.e., the saline 
pretreatment group (SAL), others received amphetamine for 
the second time during the second dialysis test session 
(AMPH-1 group), and yet others received amphetamine for 
thefifth time during the second dialysis test session (AMPH- 
4 group). In addition, in all animals a probe was lowered into 
one striatum for the first time during the second test session 
(the “naive” side) and the other striatum received a probe 
for the second time (the “used” side). Finally, one additional 
control group of rats underwent dialysis only once (control; 
n = 6), and had a dialysis probe lowered into each striaturn. 
This control group received exactly the same treatment as 
saline-pretreated animals, except no probe was lowered during 
the first dialysis test session (i.e., animals were just placed 
into the test chamber). 
At the end of the second test session, all animals received 
an overdose of sodium pentobarbital, and after the probes 
were removed, the brains were obtained for histological anal- 
ysis, as in experiment I .  
Microdialysis probe 
A removable version of a concentric-style microdialysis 
probe described previously was used (Robinson and Whishaw, 
1988; Robinson and Camp, 1991~). Briefly, the dialysis 
membrane consisted of a 4-mm length of regenerated cel- 
lulose hollow dialysis fiber with an outside diameter of 230- 
250 pm and a molecular weight cutoff of 6,000. The inlet 
line consisted of polyethylene 20 tubing and the outlet line 
of fused silica capillary tubing. 
Each probe was tested in vitro at 37°C to determine its 
ability to recover known concentrations of DA, DOPAC, 
HVA, and 5-HIAA. Recovery was determined both prior to 
implantation and again following removal of the probe from 
the brain. Probes were used for one or two experiments, and 
between experiments probe tips were kept submersed in a 
1.5% fonnalin solution. Prior to the first time a probe was 
used (preinsertion), the average relative recovery values for 
DA, DOPAC, HVA, and 5-HIAA were 25.55 f 1.19%, 25.23 
2 0.95%, 23.60 f 0.85%, and 25.58 f 1.06%, respectively. 
Following removal after their first use, the recovery values 
were 26.02 +- 0.86%, 22.38 f 0.80%, 22.28 f 0.82%, and 
24.39 f 0.93%, respectively, but the change was statistically 
significant only for DOPAC. Afler probes were used a second 
time, recovery again declined somewhat, to 24.13 2 0.77%, 
20.91 f 0.71%, 19.96 f 0.67%, and 21.63 f 0.94% for DA, 
DOPAC, HVA, and SHIAA, respectively, and this decrease 
was statistically significant for DOPAC, HVA, and 5-HIAA, 
relative to the preinsertion values. In this experiment (i.e., 
probes used in experiment I ) ,  the change in DA recovery 
was not statistically significant, but in other unpublished ex- 
periments a comparable small decrease in DA recovery was 
statistically significant. 
Assay of dialysate 
The concentrations of DA, DOPAC, HVA, and 5-HIAA 
in dialysate were determined with HPLC and oxidative-re- 
ductive electrochemical detection, as described previously 
(Robinson, 1990; Robinson and Camp, 199 la). The amount 
of each compound in dialysate was determined by compar- 
ison with the peak heights of standards run with each exper- 
iment. In addition, the purity of DA in dialysate was deter- 
mined by (1 )  comparing the retention time of DA in the 
standard to that in dialysate, (2) sometimes spiking the sample 
with DA, and (3) periodically using oxidation at a high po- 
tential (+400 mV), followed by series reduction at two dif- 
ferent points (- 1 10 and -250 rnV) on the reduction current/ 
voltage curve for DA (Matson et al., 1984). The series re- 
duction ratios for DA obtained from striatal dialysate did not 
differ from those obtained for a standard solution of DA in 
four such experiments. The minimum detection level for DA 
was about 1 fmol/min, using a criterion signatnoise ratio 
of3:I. 
Data analysis 
Data are included for only those animals in which the 
probe was placed correctly in the corpus of the neostriatum 
(see Fig. 4 in Robinson and Whishaw, 1988). In addition, 
data from one animal in experiment 2 and four animals in 
experiment 3 were excluded, because histological analysis 
revealed extensive tissue damage surrounding the probe track. 
The concentration of each compound is expressed in fem- 
tomoles per minute, corrected for probe recovery. When 
probes were reused, the appropriate recovery values were used 
(see above). It is important to note that the corrected values 
do not reflect the actual extracellular concentrations of these 
compounds, because in vitro recovery procedures do not take 
into account diffusion kinetics in a complex medium, such 
as brain (Benveniste and Hansen, 1991; Morrison et al., 
199 1). Recovery values were used here primarily to screen 
for probes with poor recovery characteristics and to control 
for experimental error due to variation in probe construction. 
Statistical analyses were performed using a Macintosh I1 
computer with Systat 5.0 and StatView I1 (Brainpower) soft- 
ware. Time-course data were analyzed using analyses of vari- 
ance (ANOVAs) with one or two repeated measures. Com- 
parisons of individual time points were made using either 
Student’s two-tailed t tests for planned comparisons, or Fish- 
er’s least significant difference (LSD) test for pairwise com- 
parisons [all two-tailed probabilities unless otherwise noted 
(Winer, 197 l)]. In addition, selected correlational analyses 
(Pearson’s r) were performed. 
RESULTS 
Experiment 1: Effects of continuous dialysis over 24 
h on the basal concentrations of DA, HVA, DOPAC, 
and 5 - H I M  in dialysate 
There was no difference between male and female 
rats and, therefore, their data were pooled for presen- 
tation in Fig. 1. Figure 1 shows the basal concentrations 
of DA and the three monoamine metabolites in dialy- 
sate during the first (0-3 h) and second (24 h later) day 
following probe insertion. The concentration of DA in 
dialysate was elevated during the first 20-min interval 
after insertion of the dialysis probe (Fig. 1A). However, 
DA levels stabilized within 40 min and remained stable 
for the next 3 h. The next day, 24 h after probe inser- 
tion, the average concentration of DA in dialysate was 
lower than the 3-h value the day before, but this dif- 
ference was not statistically significant (see Fig. 1A). 
In contrast to DA, the concentrations of DOPAC, 
J. Neurochem.. Vol. 58, No. 5 ,  I992 
REPEATED MICRODIAL YSIS 1709 
FIG. 1. The mean (* SEM) concentrations (fmol/min) 
of DA (A), DOPAC (B), HVA (C), and 5-HIAA (D) in 
8o . , 0 - 3  hr , , , ,~ 24,hr later ~ ~ . , . 0% ,~ 24, hr later 
dialysate for nine consecutive 20-min intervals im- 13000 
intervals beginning 24 h later. All four compounds .; 20 4o 1 1% f """ 1 1 B l f i m P A C ,  1; "" 1::: mediately following insertion of a dialysis probe into the striatum (0-3 h; n = 13), and for five 20-min 
showed highly significant changes over time during 
the first 3 h after probe insertion (one-way ANOVAs 
with repeated measures, all p values < 0.0001). A: 
Comparisons of individual points in time 0-3 h fol- 
lowing the first probe insertion showed that DA sta- 
bilized by the second 20-min sample (i.e., the first 
20-min interval was the only point that differed from 
any other point in time; Fisher PLSD test, p < 0.05). 
The average basal concentration of DA in dialysate 
was lower 24 h later in all animals that were tested 
on both days, except one (n = 8; x2 test, x2 = 4.5, 
p < 0.05), although in this experiment the decrease in DA was not statistically significant with a paired t test comparing the ninth 20-min 
interval on the first day with the average of the five 20-min samples collected on the second day (t = 1.42, p = 0.20). 6, C, and D: 
Comparisons of individual points in time showed that metabolite concentrations reached asymptote 100-1 40 min following probe insertion 
(Fisher PLSD tests, p < 0.05). By 24 h later, DA metabolite concentrations declined significantly, relative to the 3-h values (paired t tests; 
DOPAC: t = 9.50, p < 0.0001 ; HVA: t = 3.85, p = 0.005), but the small decrease in 5-HIAA was not significant (t = 0.96). 
. ::::yH ppij :z
4000 C. HVA D. 5-HIM 800 
2 4 6 8  2 4  2 4 6 8  2 4  
20 Minute Intervals 
HVA, and 5-HIM in dialysate steadily increased over 
the first 2 h following insertion of the probe, but reached 
asymptote by 2-3 h. However, 24 h later, there was a 
decrease in the metabolite concentrations, relative to 
the 3-h value, although this was statistically significant 
only for DOPAC and HVA. The increase in DA me- 
tabolite concentrations over the first 3 h after probe 
insertion was not due to the effects of brief anesthesia 
at the time of probe implantation, because in an in- 
dependent group of animals (n = 4) that were not 
anesthetized during the probe implantation procedure, 
a similar increase in DA metabolite concentrations was 
seen (data not shown). For example, the percent in- 
crease in DOPAC between the first and ninth sample 
was 17 1 -+ 19% in animals that were briefly anesthetized 
and 19 1 k 17% in animals that were not briefly anes- 
thetized. 
The addition of TTX to the perfusion solution pro- 
duced a significant decrease in the concentration of 
DA in dialysate, but TTX reduced DA to a significantly 
greater extent 24 h after probe implantation (to 18.63 
f 5.24% of baseline by the end of the infusion period) 
than on the same day as probe implantation (to 43.72 
f 9.64% of baseline), consistent with previous reports 
(Westerink and de Vries, 1988; Santiago and Wester- 
ink, 1990). 
Experiment 2: Effects of two probe insertions 
separated by 1 week on the basal concentrations of 
DA, DOPAC, HVA, and 5-HIAA in dialysate 
Figure 2 shows the basal concentrations of DA, DO- 
PAC, HVA, and 5-HIAA in dialysate 3 h and 24 h 
after the first probe insertion, and then again 3 h and 
24 h after the second probe insertion 1 week later. In 
this experiment, there was a statistically significant de- 
crease in the basal concentration of DA over 24 h fol- 
lowing both the first and second probe insertions (i.e,, 
the 3- and 24-h values differ in both cases; see Fig. 2A). 
There was no effect, however, of probe insertion. The 
basal concentrations of DA 3 and 24 h after the second 
probe insertion were the same as seen 3 and 24 h fol- 
lowing the first probe insertion, respectively. 
In contrast to DA, the basal concentrations of the 
DA metabolites were not stable between two probe in- 
sertions. Basal DOPAC and HVA (Fig. 2B and C) de- 
creased significantly between 3 and 24 h after the first 
probe insertion. Three hours after the second probe 
insertion, the basal concentrations of DOPAC and 
HVA were the same as seen 24 h after the first probe 
insertion, but over the next 24 h DOPAC and HVA 
decreased even further relative to all other points in 
time. The basal concentration of 5-HIAA was influ- 
enced by time after probe implantation and probe in- 
sertion in a fashion similar to that of the DA metab- 
olites (Fig. 2D), but the magnitude of the change in 
5-HIAA was much less pronounced. For example, 
DOPAC decreased by 74.8 k 4.1% between 3 h follow- 
ing the first probe insertion and 24 h following the 
second probe insertion, whereas 5-HIAA decreased by 
only 45.3 f 4.8% over this same period of time. 
Experiment 3: Effects of two probe insertions 
separated by 1 week on basal DA, DOPAC, HVA, 
and 5-HIAA, and on amphetamine-stimulated DA 
release 
Basal values. Figure 3 shows the basal concentrations 
of DAY DOPAC, HVA, and 5-HIAA in dialysate mea- 
sured 16-20 h after probe implantation in three groups. 
(1) In the first group, probes were lowered twice via the 
same guide cannula, with probe insertions separated 
by 1 week (first insertion versus second insertion in 
Fig. 3). (2) The second group consisted of the same 
animals as in (l), but the values are from probes that 
were lowered into the contralateral naive striatum only 
once, during the second test session (naive side in Fig. 
3). (3) The third group consisted of an independent 
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FIG. 2. The mean (+ SEM) basal concentrations of DA (A), DOPAC 
(B), HVA (C), and 5-HIAA (D) in dialysate: (1) 3 h and then again 
24 h after the first probe insertion (O), and (2) 3 h and 24 h after 
the second probe insertion, 1 week later (0). A: A two-way ANOVA 
with repeated measures on both factors (hours post implantation 
by insertion) showed that there was a significant decrease in DA 
between 3 and 24 h after probe insertion, and this occurred after 
both the first and second probe insertions (f = 77.95, p < 0.0001). 
There was, however, no effect of probe insertion independent of 
hours post implantation (f = 0.7, p = 0.44; interaction, f = 0.27, 
p = 0.62). B: A two-way ANOVA resulted in a significant effect of 
hours post implantation (f = 335, p < O.OOOl), a significant effect 
of probe insertion (f = 32.3, p = O.OOl), and a significant hours 
by insertion interaction (F = 29.42, p = 0.001). Subsequent paired 
t tests showed that all points differed significantly fp values i 0.006), 
except 24 h after the first insertion versus 3 h after the second 
insertion. C: The results were qualitatively the same as for DOPAC 
(effect of hours post implantation, f = 150.6, p < 0.0001; effect 
of probe insertion, f = 57.6, p < 0.0001 ; interaction, f = 15.83, 
p = 0.005). Paired comparisons were as for DOPAC fp values 
< 0.004). D: Effect of hours post implantation, F = 42.42, p < 
0.0001; effect of probe insertion, f = 21.75, p = 0.002; interaction 
nonsignificant, f = 0.68, p = 0.44. In summary, the concentration 
of DA in dialysate was stable between two probe insertions sep- 
arated by 1 week, but those of the monoamine metabolites were 
not. 
group of control animals, in which probes were lowered 
bilaterally only once, during the second test session 
(controls in Fig. 3). 
As in experiment 2, there was no difference in the 
basal concentration of DA in dialysate measured 16- 
20 h following the first versus second probe insertion. 
There was also no difference in the DA values between 
the control group and any other group, although DA 
in the naive striatum was slightly, but significantly, 
lower than in the used hemisphere during the first test 
session (i.e., first insertion in Fig. 3). Presumably, this 
latter effect reflects a chance sampling difference, be- 
cause the histological analysis showed that the probe 
placements were completely overlapping between the 
two sides. 
In contrast to DA, there was a marked decrease in 
basal DOPAC between the first and second probe in- 
sertions, confirming experiment 2 (Fig. 3). The decrease 
in DOPAC between the first and second probe inser- 
tions was also apparent relative to both the contralateral 
naive striatum and values obtained in control animals. 
HVA was also significantly lower during the second 
probe insertion, relative to the first. However, unlike 
DOPAC, no other comparisons were significant. In 
contrast to the DA metabolites, there was no difference 
in the concentration of 5-HIAA in dialysate between 
the first and second probe insertions, and none of the 
other comparisons was significant either (Fig. 3) .  
Amphetamine-stimulated DA release. Figure 4 shows 
the effect of amphetamine on the concentration of DA 
in dialysate, as a function of probe insertion in both 
amphetamine- and saline-pretreated groups. During 
the first test session, amphetamine produced a large 
increase in the concentration of DA in dialysate, which 
peaked within 20-40 min (AMPH- 1 st in Fig. 4). How- 
ever, during the second test session, the response to 
amphetamine was significantly attenuated, relative to 
the first test session (AMPH- 1 st versus AMPH-2nd in 
Fig. 4). The response of saline-pretreated animals to 
amphetamine during the second test session was also 
Mel. D A  
r r  
0 Naiveside 
0 Contmls 1 0 0 0 0 ~  
’ 
DA DOPAC HVA 5-HIAA 
FIG. 3. The mean (+ SEM) basal concentrations (fmol/min) of DA, 
DOPAC, HVA, and 5-HIAA in dialysate measured 16-20 h following 
the initial probe insertion (first insertion, n = 20), and then again 
fdlowing the second insertion of a probe via the same guide cannula 
1 week later (second insertion, n = 20; the amphetamine- and 
saline-pretreatment groups did not differ on any of the basal mea- 
sures and, therefore, were pooled for analysis here: see experiment 
3 methods). In addition, ”naive side” refers to values obtained 
from a probe lowered for the first time during the second test 
session, via a guide cannula located in the hemisphere contralateral 
to that used during the first test session (n = 20). “Controls” 
refers to values obtained with an independent group of animals (n 
= 12 probes, six rats) in which probes were lowered only once, 
bilaterally. During the first test session, these latter animals received 
exactly the same treatment as saline-pretreated animals (i.e., briefly 
anesthetized, saline injection), but no probe was lowered. The basal 
value for each individual animal consisted of the average of three 
successive 20-min baseline samples. Groups connected by a line 
above the bars differed significantly, based on unpaired or paired 
t tests ( tp  = 0.01; ‘p < 0.006, two-tailed probabilities). For DOPAC, 
the asterisk indicates that this group differed significantly from all 
other groups. No other comparisons were significant. 
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FIG. 4. The effect of a challenge injection of 2.0 mg/kg d-am- 
phetamine sulfate on the mean (5 SEM) concentration of DA in 
dialysate (fmol/min). The first three 20-min samples were obtained 
prior to amphetamine administration, which was given where in- 
dicated by the arrow. Data are shown: (1) from animals that received 
amphetamine during the first dialysis test session (AMPH-1 st, 0,  
n = 14; AMPH-4 and AMPH-1 groups pooled; see Materials and 
Methods); (2) from the same animals when they again received 
amphetamine 1 week later, the day after a probe was reinserted 
via the same guide cannula (AMPH-2nd, 0, n = 14); and (3) from 
an independent group of animals that underwent dialysis during 
the first test session, but received saline at that time; shown here 
is their response when given amphetamine for the first time during 
the second test session (SAL9nd, 0, n = 6). Amphetamine-stim- 
ulated DA release was attenuated significantly during the second 
dialysis test session in both amphetamine- and saline-pretreated 
groups relative to the first test session. AMPH-1st versus AMPH- 
2nd: two-way ANOVA with repeated measures on both factors; 
effect of probe insertion, F = 10.1, p = 0.007; effect of time after 
amphetamine, F = 74.8, p < 0.0001; insertion by time interaction, 
F = 6 .02 ,~  < 0.0001, AMPH-1st versus SAL-2nd: two-way ANOVA 
with one repeated measure (time); effect of group, F = 2.43, p 
= 0.14; effect of time, F = 33.9, p < 0.0001; interaction, F = 4.38, 
p < 0.0001. AMPH-2nd versus SAL-2nd: only the effect of time 
was significant (the group and interaction F values < 0.7). Asterisks 
indicate the individual points that differed between AMPH-1 st values 
and the comparable values for both the AMPH-2nd and SAL-2nd 
groups (p 0.05). 
significantly diminished relative to animals that re- 
ceived amphetamine during the first test session 
(AMPH- 1 st versus SAL-2nd in Fig. 4). 
A comparison of the effect of the amphetamine 
challenge during the second test session in the naive 
versus used striatum produced similar results. That is, 
during the second test session, the peak concentration 
of DA following the amphetamine challenge was sig- 
nificantly higher in both the naive striatum and control 
animals than in the used striatum (naive side = 1,280 
f 142% of baseline, controls = 1,115 f 106% of base- 
line, and the used striatum = 745 * 54% of baseline). 
However, the animals that received four previous in- 
jections of amphetamine were also analyzed separately 
(AMPH-4; see Materials and Methods). Figure 5 shows 
that amphetamine produced a significantly greater in- 
crease in DA in the naive striaturn of these animals 
than in the naive striaturn of control animals (saline- 
pretreated and control groups pooled; Fig. 5). This latter 
finding is consistent with previous reports of sensiti- 
zation following repeated administration of amphet- 
amine (e.g., Robinson et al., 1988). 
Correlational analyses 
Correlational analyses were performed on the data 
from experiment 3 to determine the relationship be- 
tween the basal concentrations of DA, DOPAC, HVA, 
and 5-HIAA in dialysate following the first versus sec- 
ond probe insertion. There was no statistically signif- 
icant correlation in basal DA between the two probe 
insertions (r = 0.221). In contrast, the basal concen- 
trations of DOPAC, HVA, and 5-HIAA measured fol- 
lowing the first probe insertion were all positively and 
significantly correlated with the respective values ob- 
tained following the second probe insertion ( r  values 
of 0.60, 0.69, and 0.74, respectively; p values < 0.01). 
Correlational analyses of the percent change in basal 
DA, basal DOPAC, and peak amphetamine-stimulated 
DA release between the two probe insertions were es- 
pecially interesting. The magnitude of the decline in 
basal DOPAC between the two probe insertions was 
significantly and positively correlated with the mag- 
nitude of the decline in peak amphetamine-stimulated 
DA release ( r  = 0.64, p < 0.00 1). However, the change 
in basal DA was not significantly correlated with the 
change in either basal DOPAC ( r  = -0.23) or am- 
phetamine-stimulated DA release ( r  = 0.00). Therefore, 
the change in basal DOPAC, but not the change in 
basal DA, predicted the change in amphetamine-stim- 
ulated DA release between two probe insertions. 
i i  
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FIG. 5. The effect of 2.0 mg/kg amphetamine given during the 
second dialysis test session on the mean (+ SEM) concentration 
of DA in dialysate obtained from the naive striatum (i.e., the side 
that did not receive a probe during the first dialysis test session). 
The first three intervals represent basal DA, and each subsequent 
interval was obtained following the amphetamine challenge (with 
values expressed as a percentage of the average baseline value). 
The amphetamine-pretreated group (B; n = 7) represents that sub- 
set of animals given amphetamine during the first dialysis test ses- 
sion, and then three additional injections of amphetamine in their 
home cage between the first and second test sessions (see text 
for details). The control group (0; n = 18) consisted of those animals 
that received amphetamine for the first time during the second 
test session (saline-pretreated and control groups pooled). The 
challenge injection produced a significantly greater increase in DA 
in the naive striatum of amphetamine-pretreated animals than in 
the naive striatum of the control group (two-way ANOVA with re- 
peated measures: effect of pretreatment, F = 4.17, p = 0.053; 
interaction, F = 2.4, p = 0.013; ' p  = 0.05, independent t tests, 
one-tailed probabilities). The sensitization of amphetamine-stimu- 
lated DA release was predicted on the basis of previous between- 
subjects design studies (e.g., Robinson et al., 1988). which is why 
one-tailed tests were used. 
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DISCUSSION 
The experiments reported here revealed a consistent 
dissociation in the effects of two insertions of a dialysis 
probe into the same site on basal DA versus other mea- 
sures of DA neurotransmission. For example, there was 
no significant difference in the basal concentration of 
DA in dialysate between two probe insertions separated 
by 1 week, whereas the basal concentrations of DOPAC 
and HVA in dialysate progressively decreased. Like 
the DA metabolites, the ability of amphetamine to el- 
evate DA in dialysate was greatly attenuated following 
a second probe insertion, and the magnitude of the 
decrease in amphetamine-stimulated DA release was 
positively correlated with the magnitude of the decrease 
in basal DOPAC. The implications of these findings 
for the use of within-subjects design dialysis experi- 
ments involving multiple probe insertions at the same 
site are discussed below. 
Effects of two probe insertions on the basal 
concentration of DA and monoamine metabolites in 
dialysate 
If the effects of insertion and reinsertion of a small 
diameter, concentric-style dialysis probe on basal DA 
were considered in isolation, it would appear that the 
nigrostriatal DA system was not disturbed markedly 
by the procedures employed here. Not only did basal 
DA stabilize quickly after each probe insertion, but it 
remained stable across two insertions of a probe at the 
same site. Using the concentric-style probe described 
here, Robinson and Camp ( 199 1 b) also found no sig- 
nificant decrease in basal DA over 4 days of continuous 
dialysis. Thus, measures of basal DA suggest that mul- 
tiple probe insertions at the same site may provide a 
reasonable approach for within-subjects design dialysis 
experiments. On the other hand, there was not a sig- 
nificant correlation in basal DA between two probe 
insertions separated by 1 week, and the effects of two 
probe insertions on DA metabolism were not encour- 
aging. 
The basal concentrations of the DA metabolites, 
DOPAC and HVA, progressively increased over the 
first 2-3 h after probe implantation and then decreased 
significantly 24 h later. By 24 h following the second 
probe insertion, basal DOPAC and HVA had declined 
even further. Consistent with this, Robinson and Camp 
(1991 b) reported a progressive decrease in the basal 
concentration of DA metabolites in dialysate over 4 
days of continuous dialysis. It is important to consider, 
therefore, what a decrease in DA metabolites tells us 
about the nature of probe-induced alterations in the 
nigrostriatal DA system. One possibility is that the 
changes in DOPAC reflect the extent to which the ni- 
grostriatal DA system was compromised by the dialysis 
procedure. The implication of this, of course, is that 
DOPAC better reflects the integrity of the dopaminergic 
input to the striatum than does the basal concentration 
of DA. Although this may seem counterintuitive at 
first, such an interpretation is consistent with micro- 
dialysis studies in which the nigrostriatal DA system 
was deliberately damaged by use of either 6-hydroxy- 
dopamine (6-OHDA) or neurotoxic doses of meth- 
amphetamine (Robinson and Whishaw, 1988; Touchet 
and Bennett, 1989; Abercrombie et al., 1990; Casta- 
iieda et al., 1990; for review, see Robinson et al., 1990). 
It has been shown that the postmortem tissue con- 
centration of DA in the striatum can be depleted by 
up to 80%, with no change in the basal concentration 
of DA in stnatal dialysate (Robinson et al., 1990). Fol- 
lowing a neurotoxic lesion, the postmortem tissue con- 
centration of DA is known to provide a good index of 
the magnitude of DA denervation and the extent of 
cell loss in the substantia nigra (Ranje and Ungerstedt, 
1977; Onn et al., 1986). Destruction of 80-95% ofthe 
DA innervation in the striatum produces more variable 
effects, although after recovery some animals with even 
this degree of DA denervation still have basal levels of 
dialysate DA within the control range (Castaiieda et 
al., 1990). Only after a lesion destroys over 95% of the 
DA input to the striatum is there a consistent and 
marked decrease in dialysate DA (Castaiieda et al., 
1990). The normalization of basal DA in dialysate seen 
following partial damage to the nigrostriatal DA system 
is thought to be due to the interaction of many pre- 
synaptic compensatory changes in the remaining DA 
terminals, including an increase in DA synthesis and 
release and a decrease in DA reuptake (Robinson et 
al., 1990; Zigmond et al., 1990). Presumably, it is be- 
cause of these neuroplastic adaptations that the basal 
concentration of DA in dialysate is such a poor indi- 
cator of the integrity of the nigrostriatal DA system. 
In contrast to DA, a 6-OHDA lesion produces a de- 
crease in the concentration of DOPAC in dialysate that 
is proportional to the extent of the lesion (Zhang et al., 
1988; Altar and Marien, 1989; Castaiieda et al., 1990). 
The integrity of the nigrostriatal DA input to the stria- 
tum may be predicted by basal DOPAC in dialysate, 
but not by basal DA, because DOPAC largely reflects 
DA that is metabolized intruneuronally, independent 
of DA release (Zetterstrom et al., 1988; Kuczenski and 
Segal, 1989). This source of DOPAC would be de- 
creased in proportion to the loss of DA terminals fol- 
lowing a lesion. In summary, it is suggested that the 
decrease in basal DOPAC seen between two probe in- 
sertions indicates the extent of damage to the striatum, 
and this was not reflected by a change in basal DA, 
because damage-evoked compensatory adaptations 
were sufficient to maintain a normal extracellular con- 
centration of DA (Robinson et al., 1990). 
It is also interesting that two probe insertions had a 
much smaller effect on the basal concentration of the 
serotonin metabolite, 5-HIAA, than on the DA me- 
tabolites. This suggests that the dissociation between 
DA and its metabolites discussed above was not due 
to a nonspecific change in the recovery of acids from 
the extracellular fluid. This is also consistent with the 
observation that, relative to the DA metabolites, basal 
5-HIAA shows only modest changes over 4 days of 
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continuous dialysis (Reiriz et al., 1989; Robinson and 
Camp, 199 1 b). 
Effect of two probe insertions on amphetamine- 
stimulated DA release 
The effect of two probe insertions on amphetamine- 
stimulated DA release was similar to that on basal DO- 
PAC, i.e., the ability of amphetamine to elevate DA 
in dialysate was decreased markedly between two probe 
insertions separated by 1 week. There are several pos- 
sible explanations for this decreased responsivity to 
amphetamine. First, high doses of amphetamine are 
known to be neurotoxic, causing degeneration of stria- 
tal DA terminals, DA depletion in postmortem tissue, 
a reduced number of DA reuptake sites, and decreased 
tyrosine hydroxylase activity (Seiden and Ricaurte, 
1987). It is important to consider, therefore, whether 
the decrease in amphetamine-stimulated DA release 
between the two test sessions (and the decrease in 
DOPAC) could be secondary to amphetamine neu- 
rotoxicity. This is unlikely for three reasons. (1) In the 
present study, a relatively low dose of amphetamine 
was used, and neurotoxicity has been reported only 
after much higher doses (Robinson and Becker, 1986). 
This is not a strong argument, however, because tissue 
already damaged by probe implantation could be more 
susceptible to amphetamine neurotoxicity (e.g., Phebus 
et al., 1991). It is important, therefore, that (2) saline- 
pretreated rats also showed an attenuated response to 
amphetamine during the second test session, and (3) 
the response in the contralateral naive striatum, which 
had a probe lowered into it for the first time during 
the second dialysis test session, was similar to that seen 
during the first dialysis test session. These latter two 
points indicate that it was probe implantation, and not 
prior experience with amphetamine, that was respon- 
sible for the decrease in amphetamine-stimulated DA 
release. 
Another possibility is that often the same dialysis 
probe was used in different animals, at different times, 
and although the brain is considered immunologically 
privileged, proteins remaining on the probe from one 
animal could have triggered a negative tissue reaction 
when used in a different animal. To rule this out, ap- 
proximately half of the animals in the third experiment 
received newly constructed probes in both the first and 
second test sessions. Amphetamine-stimulated DA re- 
lease in these animals was identical to that in animals 
which had dialysis performed with a previously used 
probe (data not shown). 
A third possible explanation for the decline in am- 
phetamine-stimulated DA release between two test 
sessions is that it reflects the extent of damage to the 
nigrostriatal DA system in the same manner as the 
decrease in basal DOPAC (see above). This idea is sup- 
ported by the strong positive correlation between the 
magnitude of the decrease in amphetamine-stimulated 
DA release and the magnitude of the decrease in basal 
DOPAC. One problem with this interpretation, how- 
ever, is that Castaiieda et al. (1990) reported that de- 
struction of up to 80% of the DA input to the striatum 
with 6-OHDA had no significant effect on amphet- 
amine-stimulated DA release, despite a decrease in 
basal DOPAC. That is, following a partial 6-OHDA 
lesion, compensatory adaptations were not only suffi- 
cient to normalize basal DA, but arnphetamine-stim- 
dated DA release as well. The reason for a difference 
in the effects of probe implantation versus a 6-OHDA 
lesion on amphetamine-stimulated DA release is not 
clear. 
One procedural difference is that Castaiieda et al. 
(1990) tested animals approximately 1 month after a 
6-OHDA lesion, whereas in the present study animals 
were retested for amphetamine-stimulated DA release 
1 week after the first test session (i.e., 1 week after the 
damage produced by the initial probe insertion). Per- 
haps 1 week is not sufficient time for recovery. Another 
possibility, however, may be related to the fact that 
probe implantation and 6-OHDA produce a very dif- 
ferent type of lesion. The lesion produced by probe 
implantation is focal and nonspecific. A 6-OHDA le- 
sion, on the other hand, produces a fairly specific and 
diffuse “pruning” of the entire DA input to the stria- 
tum. It is known that this latter treatment results in a 
marked increase in DA synthesis in the surviving ter- 
minals (Zigmond et al., 1984; Wolfet al., 1989), which 
may play an important role in the ability of the sur- 
viving DA neurons to maintain relatively normal levels 
of amphetamine-stimulated DA release. Perhaps fol- 
lowing probe implantation there is not a comparable 
increase in DA synthesis in the surviving DA terminals, 
because the focal nature of the injury does not provide 
a sufficient “signal” for up-regulation of DA synthesis. 
Thus, following reinsertion of the dialysis probe, the 
rate of DA synthesis may be sufficient to maintain the 
basal concentration of DA in dialysate, but not suffi- 
cient to meet the demand for increased DA release 
imposed by a challenge injection of amphetamine. 
Conclusions 
In conclusion, these experiments suggest that within- 
subjects design studies using repeated probe insertions 
at the same site in the striatum of rats are probably ill- 
advised, at least with the methods and materials used 
here. This does not rule out the possibility of repeated 
dialysis in the same rat, but at dzferent sites, or repeated 
microdialysis at the same site in larger animals (Ken- 
drick, 199 I) ,  and/or in other neurotransmitter systems. 
Nevertheless, if a within-subjects design is used for mi- 
crodialysis, it should be incumbent upon the investi- 
gator to demonstrate whether the integrity of the neural 
system under study is maintained between test sessions. 
The data presented here and by Robinson and Camp 
( 199 1 b) suggest that a stable basal concentration of a 
neurotransmitter in dialysate does not constitute suf- 
ficient evidence and, in fact, the transmitter itself may 
be the least sensitive indicator of system integrity. 
J. Neurochem., Vol. 58, No. 5 ,  1992 
1714 D. M. CAMP AND T. E. ROBINSON 
Acknowledgment: The  research reported here was sup- 
ported by grant no. 04294 from the National Institute on 
Drug Abuse. We thank Zoltan Mocsary and Erin Wolfe for 
their assistance in  conducting some of the experiments. Por- 
tions of the data reported here were presented previously in  
abstract form (Camp and Robinson, 1989, 1990) and in a n  
edited book chapter (Robinson and Camp,  1991). 
REFERENCES 
Abercrombie E. D., Bonatz A. E., and Zigmond M. J. (1990) Effects 
of /-Dopa on extracellular dopamine in striatum of normal and 
6-hydroxydopamine-treated rats. Brain Res. 525, 36-44. 
Altar C. A. and Marien M. R. (1989) Preservation of dopamine release 
in the denervated striaturn. Neurosci. Lett. 96, 329-334. 
Benveniste H. and Diemer N. H. (1987) Cellular reactions to im- 
plantation of a microdialysis tube in the rat hippocampus. Acta 
Neuropathol. [Berl). 14, 234-238. 
Benveniste H. and Hansen A. J. (1991) Practical aspects of using 
microdialysis for determination of brain interstitial concentra- 
tions, in Microdialysis in the Neurosciences (Robinson T. E. 
and Justice J. B. Jr., eds), pp. 81-100. Elsevier, Amsterdam. 
Camp D. M. and Robinson T. E. (1989) A method for repeated 
intracerebral microdialysis. SOC. Neurosci. Abstr. 15, 559. 
Camp D. M. and Robinson T. E. (1990) Repeated intracerebral mi- 
crodialysis for the measurement of stimulated dopamine release. 
Soc. Neurosci. Abstr. 16, 130. 
Castaiieda E., Whishaw I. Q., and Robinson T. E. (1990) Changes 
in striatal dopamine neurotransmission assessed with microdi- 
alysis following recovery from a bilateral 6-OHDA lesion: vari- 
ation as a function of lesion size. J. Neurosci. 10, 1847-1854. 
Imperato A. and Di Chiara G. ( I  984) Trans-stnatal dialysis coupled 
to reverse phase high performance liquid chromatography with 
electrochemical detection: a new method for the study of the in 
vivo release of endogenous dopamine and metabolites. J .  Neu- 
rosci. 4,966-977. 
Imperato A. and Di Chiara G. (1985) Dopamine release and metab- 
olism in awake rats after systemic neuroleptics as studied by 
trans-stnatal dialysis. J .  Neurosci. 5, 297-306. 
Kalivas P. W. and Duffy P. (1990) Effect of acute and daily cocaine 
treatment on extracellular dopamine in the nucleus accumbens. 
Synapse 5,48-58. 
Kendrick K. M. (1991) Microdialysis in large unrestrained animals: 
neuroendocrine and behavioral studies of acetylcholine, amino 
acid, monoamine and neuropeptide release in the sheep, in Mi- 
crodialysis in the Neurosciences (Robinson T. E. and Justice 
J. B. Jr., eds), pp. 327-348. Elsevier, Amsterdam. 
KorfJ. and Venema K. (1985) Amino acids in rat striatal dialysates: 
methodological aspects and changes after electroconvulsive 
shock. J.  Netcrochem. 45, 1341- 1348. 
Kuczenski R. and Segal D. (1989) Concomitant characterization of 
behavioral and striatal neurotransmitter response to amphet- 
amine using in vivo microdialysis. J. Neurosci. 9, 205 1-2065. 
Matson W. R., Langlais P., Volicer L., Gamache P. H., Bird E., and 
Mark K. A. (1984) n-Electrode threedimensional liquid chro- 
matography with electrochemical detection for determination 
of neurotransmitters. Clin. Chem. 30, 1477- 1488. 
Moghaddam B. and Bunney B. S. (1989) Ionic composition of mi- 
crodialysis perfusing solution alters the pharmacological re- 
sponsiveness and basal outflow of striatal dopamine. J. Neuro- 
chem. 53,652-654. 
Morrison P. F., Bungay P. M., Hsiao J. K., Mefford 1. N., Dykstra 
K. H., and Dedrick R. L. (1991) Quantitative microdialysis, in 
Microdialysis in the Neurosciences (Robinson T. E. and Justice 
J .  B. Jr., eds), pp. 47-80. Elsevier, Amsterdam. 
Myers R. D. (1977) Chronic methods: intraventricular infusion, ce- 
rebrospinal fluid sampling and push-pull perfusion, in Methods 
in Psychobiology (Myers R. D., ed), pp. 281-315. Academic 
Press, New York. 
Onn S. P., Berger T. W., Stricker E. M., and Zigmond M. J. (1986) 
Effects of intraventricular 6-hydroxydopamine on the dopami- 
nergic innervation of striatum: histochemical and neurochemical 
analysis. Brain Res. 376, 8- 19. 
Pettit H. 0. and Justice J. B. Jr. (1991) Effect ofdose on cocaine self- 
administration behavior and dopamine levels in the nucleus ac- 
cumbens. Brain Rex 539, 94-102. 
Phebus L. A., Mincy R. E., and Clemens J.  A. (1991) Microdialysis 
perfusion accelerates striatal ischemic damage. Curr. Separations 
10, 114. 
Ranje C. and Ungerstedt U. ( I  977) High correlations between number 
of dopamine cells, dopamine levels and motor performance. 
Brain Res. 134, 83-93. 
Reiriz J., Mena M. A., Bazan E., Muradas V., Lerma J., Delgado 
J. M.. and De Yebenes J. G. (1989) Temporal profile of levels 
of monoamines and their metabolites in striata of rats implanted 
with dialysis tubes. J.  Neurochem. 53, 789-792. 
Robinson T. E. ( 1  990) Coirlachem Applications: Mccrodialysates. ESA 
Co., Bedford, Massachusetts. 
Robinson T. E. and Becker J. B. (1986) Enduring changes in brain 
and behavior produced by chronic amphetamine administration: 
a review and evaluation of animal models of amphetamine psy- 
chosis. Brain Res. Rev. 396, 157-198. 
Robinson T. E. and Camp D. M. (199 la) The feasibility of repeated 
microdialysis for within-subjects design experiments: studies on 
the mesostriatal dopamine system, in Microdialysis in the Neu- 
rosciences (Robinson T. E. and Justice J. B. Jr., eds), pp. 189- 
234. Elsevier, Amsterdam. 
Robinson T. E. and Camp D. M. ( I  99 Ib) The effects of four days of 
continuous striatal microdialysis on indices of dopamine and 
serotonin neurotransmission in rats. J. Neurosci. Methods (in 
press). 
Robinson T. E. and Whishaw I. Q. (1988) Normalization of extra- 
cellular dopamine in striatum following recovery from a partial 
unilateral 6-OHDA lesion of the substantia nigra: a microdialysis 
study in freely moving rat. Brain Res. 450, 209-224. 
Robinson T. E., Jurson P. A., Bennett J. A., and Bentgen K. M. 
( 1988) Persistent sensitization of dopamine neurotransmission 
in ventral striatum (nucleus accumbens) produced by past ex- 
perience with (+)-amphetamine: a microdialysis study in freely 
moving rats. Brain Res. 462, 2 1 1-222. 
Robinson T. E., Castaaeda E., and Whishaw I. Q. (1990) Compen- 
satory changes in striatal dopamine neurons following recovery 
from injury induced by 6-OHDA or methamphetamine: a review 
of evidence from microdialysis studies. Can. J. Psychol. 44,253- 
275. 
Santiago M. and Westerink B. H. C. (1990) Characterization of the 
in vivo release of dopamine as recorded by different types of 
intracerebral microdialysis probes. Naunyn-Schmiedebergs Arch. 
Pharmacol. 342,407-4 14. 
Seiden L. S. and Ricaurte G. A. ( 1  987) Neurotoxicity of metham- 
phetamine and related drugs, in Psychopharmacology: The Third 
Generation qfProgress (Meltzer H. Y., ed), pp. 359-366. Raven 
Press, New York. 
Touchet N. and Bennett J .  J. ( 1  989) The metabolism ofsystemically- 
administered L-dihydroxyphenylalanine, by intact and dopa- 
mine-denervated striata, as revealed by brain microdialysis. 
Neuropharmacology 28, 12 1 I- 1222. 
Ungerstedt U. (1984) Measurement of neurotransmitter release by 
intracranial dialysis, in Measurement of Neurotransmitter Release 
In Vivo (Marsden C. A,, ed), pp. 81-105. John Wiley and Sons, 
New York. 
Westerink B. H. and de Vries J. B. (1988) Characterization of in vivo 
dopamine release as determined by brain microdialysis after acute 
and subchronic implantations: methodological aspects. J. Neu- 
rochem. 51,683-687. 
Waterink B. H. and Tuinte M. H. (1986) Chronic use ofintracerebral 
dialysis for the in vivo measurement of 3,4-dihydroxyphenyle- 
thylamine and its metabolite 3,4-dihydroxyphenylacetic acid. J. 
Neurochem. 46, 181-185. 
Westerink B. H., Damsma G., Rollema H., De Vries J. B., and Horn 
A. S. (1987) Scope and limitations of in vivo brain dialysis: a 
J.  Neurochem , Vol. 58. No. 5. 1992 
REPEA TED MICRODIAL YSIS 1715 
comparison of its application to various neurotransmitter sys- 
tems. Life Sci. 41, 1763-1776. 
Winer B. J. (197 1) Statistical Principles in Experimental Design. 
McGraw-Hill, New York. 
Wolf M. E., Zigmond M. J., and Kapatos G .  (1989) Tyrosine hy- 
droxylase content of residual dopamine terminals following 6- 
hydroxydopamine administration: a flow cytometnc study. J. 
Neurochem. 53,879-885. 
Zetterstrom T., Sharp T., Collin A. K., and Ungerstedt U. (1988) In 
vivo measurement of extracellular dopamine and DOPAC in 
rat striatum after various dopamine-releasing drugs; implications 
for the origin of extracellular DOPAC. Eur. J.  Pharmacol. 148, 
327-334. 
Zhang W. Q., Tilson H. A., Nanry K. P., Hudson P. M., Hong J. S., 
and Stachowiak M. K. (1988) Increased dopamine release from 
striata of rats after unilateral nigrostriatal bundle damage. Brain 
Res. 461, 335-342. 
Zigmond M. J., Acheson A. L., Stachowiak M. K., and Stricker 
E. M. ( 1984) Neurochemical compensation after nigrostriatal 
bundle injury in an animal model of preclinical parkinsonism. 
Arch. Neurol. 41, 856-86 1. 
Zigmond M. J., Abercrombie E. D., Berger T. W., Grace A. A,, and 
Stricker E. M. (1990) Compensations after lesions of central 
dopaminergic neurons: some clinical and basic implications. 
Trends Neurosci. 13, 290-296. 
J.  Neurochem., Vol. 58, No. 5, 1992 
